Preoperative GLP-1 Agonist Use Is Associated with Decreased Complications Compared to Bariatric Surgery Following Primary Total Hip Arthroplasty

Preoperative GLP-1 Agonist Use Is Associated with Decreased Complications Compared to Bariatric Surgery Following Primary Total Hip Arthroplasty
Obesity is a risk factor for adverse outcomes following total hip arthroplasty (THA). While weight loss strategies exist, the comparative impact of these approaches on surgical outcomes remains underexplored. This study aimed to compare complications among patients who had bariatric surgery versus prescription weight-loss medications prior to THA.

Take Your Experience to the Next Level

New

Download our mobile app for a faster and better experience.

Comments

0
U

Join the discussion

Sign in to leave a comment

0:000:00